FUSEFUSE in focus: Fusemachines draws Nasdaq deficiency notice on market value, has until January 20, 2027 to complyJul 25SLNHSoluna Holdings sets CEO Belizaire's base salary at $600,000, retroactive to January, with 100% bonus targetJul 25MDMD names David Haddock general counsel as Mary Ann Moore's Pediatrix exit takes formal shapeJul 25MARKETSSSD declares $0.30 quarterly cash dividend, ex-date and record date set for October 1Jul 25MARKETSBLUBF declares CAD 0.04 monthly cash dividend with August 31 ex-dateJul 25CNXCConcentrix CNXC board adopts amended severance plan with 2x change-of-control payout and new standalone benefitJul 24QSIQSI in focus: Quantum-Si receives Nasdaq minimum bid price notice, faces January 19 compliance deadlineJul 24INSPInspire Medical Systems adds AtriCure CEO Michael Carrel to board in July 20 appointmentJul 24MARKETSCapital expenditure in focus as Alphabet raises the AI spending bar, three hyperscalers left to reportJul 24FJETFJET 8-K: Starfighters Space names CBIZ CPAs as auditor with STARLAUNCH program in Critical Design ReviewJul 24FUSEFUSE in focus: Fusemachines draws Nasdaq deficiency notice on market value, has until January 20, 2027 to complyJul 25SLNHSoluna Holdings sets CEO Belizaire's base salary at $600,000, retroactive to January, with 100% bonus targetJul 25MDMD names David Haddock general counsel as Mary Ann Moore's Pediatrix exit takes formal shapeJul 25MARKETSSSD declares $0.30 quarterly cash dividend, ex-date and record date set for October 1Jul 25MARKETSBLUBF declares CAD 0.04 monthly cash dividend with August 31 ex-dateJul 25CNXCConcentrix CNXC board adopts amended severance plan with 2x change-of-control payout and new standalone benefitJul 24QSIQSI in focus: Quantum-Si receives Nasdaq minimum bid price notice, faces January 19 compliance deadlineJul 24INSPInspire Medical Systems adds AtriCure CEO Michael Carrel to board in July 20 appointmentJul 24MARKETSCapital expenditure in focus as Alphabet raises the AI spending bar, three hyperscalers left to reportJul 24FJETFJET 8-K: Starfighters Space names CBIZ CPAs as auditor with STARLAUNCH program in Critical Design ReviewJul 24

FUSE in focus: Fusemachines draws Nasdaq deficiency notice on market value, has until January 20, 2027 to comply

A Nasdaq deficiency notice reached Fusemachines Inc. (FUSE) on July 24, 2026, flagging the New York-headquartered company's failure to maintain the $15,000,000 minimum Market Value of Publicly Held Shares required for the Nasdaq Global Market under Listing Rule 5450(b)(2)(C). The notice carries no immediate effect on trading; FUSE common stock and warrants (FUSEW) remain listed during the compliance period. The clock now runs to January 20, 2027.

By Marcus ColeMacro DeskJuly 25, 20262 min readFUSE
Share

Key takeaways

  • Fusemachines Inc. (FUSE) received a Nasdaq deficiency notice on July 24, 2026 for failing to maintain the $15,000,000 minimum Market Value of Publicly Held Shares required under Listing Rule 5450(b)(2)(C).
  • The notice has no immediate effect on trading, and FUSE common stock and FUSEW warrants remain listed during the compliance period.
  • The company has 180 calendar days, until January 20, 2027, to regain compliance under Nasdaq Listing Rule 5810(c)(3)(D).
  • To regain compliance, Fusemachines' MVPHS must close at or above $15,000,000 for at least 10 consecutive business days.
  • The 8-K, signed by CEO Sameer Maskey, states the company intends to monitor its MVPHS and assess options but names no specific remediation plan or corporate action.

A Nasdaq deficiency notice reached Fusemachines Inc. (FUSE) on July 24, 2026, flagging the New York-headquartered company's failure to maintain the $15,000,000 minimum Market Value of Publicly Held Shares required for the Nasdaq Global Market under Listing Rule 5450(b)(2)(C). The notice carries no immediate effect on trading; FUSE common stock and warrants (FUSEW) remain listed during the compliance period. The clock now runs to January 20, 2027.

The compliance threshold

Nasdaq's Listing Qualifications Department found that Fusemachines' MVPHS stayed below $15,000,000 for 30 consecutive business days, from June 10, 2026 through July 23, 2026. That sustained stretch triggered the formal deficiency letter.

Under Nasdaq Listing Rule 5810(c)(3)(D), the company has 180 calendar days to address the shortfall. The path back: MVPHS must close at or above $15,000,000 for a minimum of 10 consecutive business days, at which point Nasdaq will provide written confirmation that the deficiency is resolved.

What the 8-K discloses

The filing, signed by CEO Sameer Maskey, states the company intends to monitor its MVPHS and assess available options during the compliance period. No specific remediation plan or corporate action is named. Fusemachines is incorporated in Delaware and headquartered at 200 West 41st Street, 21st Floor, New York, New York 10036.

The company carries Commission File Number 001-42909 and is classified as an emerging growth company. Its most recent Annual Report on Form 10-K, covering the fiscal year ended December 31, 2025, was filed with the SEC on March 27, 2026.

What to watch

The setup reduces to one number: $15,000,000 in MVPHS held for 10 consecutive sessions. No timetable for a remediation plan or specific corporate action appears in the filing. The Notification Letter, Fusemachines notes in the 8-K, does not itself affect the listing or trading of the stock while the company works through the compliance window.

Until a concrete strategy is disclosed or the MVPHS metric recovers to the required level, the tape will track whether the public float value can close at or above that threshold and hold it for the required stretch. The 8-K was filed July 24, 2026, the same date the Notification Letter arrived from Nasdaq's Listing Qualifications Department.

About this story

Filed by the macro desk of MarketPR on July 25, 2026. Source: MarketPR. Indicative figures are not investment advice.

Back to the news index

Frequently asked

Why did Fusemachines receive a Nasdaq deficiency notice?

Its Market Value of Publicly Held Shares stayed below the $15,000,000 minimum for 30 consecutive business days, from June 10, 2026 through July 23, 2026, violating Listing Rule 5450(b)(2)(C).

Does the notice affect trading of FUSE stock?

No, the notice carries no immediate effect on trading, and FUSE common stock and FUSEW warrants remain listed during the compliance period.

What must Fusemachines do to regain compliance?

Its MVPHS must close at or above $15,000,000 for a minimum of 10 consecutive business days, after which Nasdaq will provide written confirmation that the deficiency is resolved.

What is the deadline to comply?

The company has 180 calendar days, running to January 20, 2027, to address the shortfall.

Where is Fusemachines located and incorporated?

The company is incorporated in Delaware and headquartered at 200 West 41st Street, 21st Floor, New York, New York 10036.